United Therapeutics CEO Martine Rothblatt disposes 9,500 shares for $5.49 million
Share
Listen to the news
United Therapeutics CEO Martine Rothblatt disposes 9,500 shares for $5.49 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 146.03 on April 16, 2026.
  • Rothblatt sold 9,500 shares on April 16, 2026 at weighted average prices of about USD 573.96 to USD 581.33.
  • Directly held common stock ended day at 40,513 shares.
  • Rothblatt continued to beneficially own shares indirectly, including 324,443 shares held by trust.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000034), on April 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending